Latest / Cork News Today | 2 Min News | The Daily News Now!
Skyclarys Access Battle in Ireland | Cork News
Ireland’s health system faces a high-stakes showdown over whether to fund Skyclarys, a life-changing drug for Friedreich’s ataxia, as Biogen clashes with the HSE over cost and clinical value. With patients and families on edge ahead of an August 25 deadline, advocacy groups rally for access — including national protests in Dublin — as the fate of hundreds of people hinges on negotiations shrouded in commercial secrecy. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated, high-level news summary based…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.